Physiological basis and indications of treatment of erectile dysfunction with the phosphodiesterase inhibitor sildenafil citrate
J. bras. urol
;
25(2): 161-71, abr.-jun. 1999. tab
Article
Dans Anglais
| LILACS
| ID: lil-246361
RESUMO
The advent of the first effective oral agent in the management of erectile dysfunction, sildenafil, has had a revolutionary impact in the medical societal and economic aspects of this field. This review will examine the clinical research and field experience with respect to efficacy and safety as well as touch on the broader societal and economic issues related to sildenafil. The following topics are extensively presented and discussed in this article molecular pharmacology, pharmacokinetics and pharmacokinetics in special populations (geriatrics, renal insufficiency, hepatic insufficiency). The indications, contraindications and precautions. Dosage and administration, efficacy in general and in diabetic patients, spinal cord injured patients, radical prostatectomy, and according to age and severity of erectile dysfunction. The safety and the side effects are also discussed
Recherche sur Google
Indice:
LILAS (Amériques)
Sujet Principal:
Inhibiteurs de la phosphodiestérase
/
Dysfonctionnement érectile
Limites du sujet:
Adulte
/
Humains
/
Mâle
langue:
Anglais
Texte intégral:
J. bras. urol
Thème du journal:
Urologie
Année:
1999
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS